Skip to main content

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Project description

A simple oral treatment for the neglected disease cutaneous leishmaniasis

Many diseases that are not life-threatening in developed countries, do not receive the resources and attention required to investigate prevention, treatment or cure. Cutaneous leishmaniasis (CL), caused by a parasite transmitted via infected sand flies, is one among them. Infections are common in low-income populations of developing regions. Producing ulcers, sometimes up to 200, on exposed parts of the body, CL can leave permanent scars that are often the source of extreme social prejudice. TT4CL is working hard to bring a promising oral treatment for CL into clinical trials. Registration with regulatory agencies requiring proof of conformance to stringent safety, efficacy and tolerability requirements could change the lives of millions of people globally.

Call for proposal

H2020-SC1-BHC-2018-2020

See other projects for this call

Sub call

H2020-SC1-2018-Two-Stage-RTD

Coordinator

ST GEORGE'S HOSPITAL MEDICAL SCHOOL
Net EU contribution
€ 1 143 863,88
Address
Cranmer Terrace
SW17 0RE London
United Kingdom

See on map

Region
London Inner London — West Wandsworth
Activity type
Higher or Secondary Education Establishments
Other funding
No data

Participants (7)

OBLITA THERAPEUTICS
Belgium
Net EU contribution
€ 367 550,00
Address
Rodendijk 40
2980 Zoersel

See on map

Region
Vlaams Gewest Prov. Antwerpen Arr. Antwerpen
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
No data
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER
United Kingdom
Net EU contribution
€ 390 568,08
Address
Keppel Street
WC1E 7HT London

See on map

Region
London Inner London — West Camden and City of London
Activity type
Higher or Secondary Education Establishments
Other funding
No data
AVIVIA BEHEER BV
Netherlands
Net EU contribution
€ 591 000,00
Address
Transistorweg 5
6534AT Nijmegen

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Oost-Nederland Gelderland Arnhem/Nijmegen
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
No data
EBERHARD KARLS UNIVERSITAET TUEBINGEN
Germany
Net EU contribution
€ 670 150,01
Address
Geschwister-scholl-platz
72074 Tuebingen

See on map

Region
Baden-Württemberg Tübingen Tübingen, Landkreis
Activity type
Higher or Secondary Education Establishments
Other funding
No data
Third-party

Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.

Universitaetsklinikum Tuebingen
Germany
Net EU contribution
€ 40 000,00
Address
Geissweg 3
72076 Tuebingen

See on map

Region
Baden-Württemberg Tübingen Tübingen, Landkreis
Activity type
Research Organisations
Other funding
No data
TEHRAN UNIVERSITY OF MEDICAL SCIENCES
Iran
Net EU contribution
€ 371 375,55
Address
Office Of Vice Chancellor For Global Strategies An International Affairs No 21 Dameshgh St Vali E Asr Ave
1416753955 Tehran

See on map

Activity type
Higher or Secondary Education Establishments
Other funding
No data
UNIVERSITY OF YORK
United Kingdom
Net EU contribution
€ 178 628,04
Address
Heslington
YO10 5DD York North Yorkshire

See on map

Region
Yorkshire and the Humber North Yorkshire York
Activity type
Higher or Secondary Education Establishments
Other funding
No data